RUBICON RESEARCH LIMITED
Related Stocks
About
Rubicon Research Limited operates as a specialty pharmaceutical company in India, the United States, and internationally. Its primary proprietary technologies for drug delivery comprising RubiSRL for the formulation of sustained release liquids using a combination of ion exchange and membrane diffusion controlled-release technologies; and RubiReten, a gastro-retentive system for drugs with poor solubility and a limited window of absorption. The company develops products in the areas of analgesics/pain management, hypokalemia, gastrointestinal, cardiovascular, skeletal muscle relaxants, metabolic, central nervous system, nicotine replacement therapy, and immunosuppressant. The company was incorporated in 1999 and is based in Mumbai, India.
Price Range
52 Week
Low
570.75
High
1,819.00
Intraday
Low
1,750.00
High
1,819.00
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
Peer Comparison
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|
| 1 | RUBICON RESEARCH LIMITED | 1,798.50 | +0.04% | 117.91 | 15.31 | 29,864 | 1,819.00 | 570.75 |
| 2 | CORONA REMEDIES LIMITED | 2,117.20 | +0.19% | 65.14 | 32.54 | 12,975 | 2,270.10 | 1,336.60 |
| 3 | GlaxoSmithKline Pharmaceuticals Limited | 2,815.30 | +4.16% | 44.79 | 63.05 | 47,414 | 2,883.40 | 2,088.10 |
| 4 | Marksans Pharma Limited | 326.25 | -1.66% | 28.55 | 11.41 | 14,752 | 345.50 | 155.00 |
| 5 | NGL Fine-Chem Limited | 3,032.40 | +4.28% | 32.77 | 92.73 | 1,874 | 3,602.00 | 1,271.00 |
| 6 | Pfizer Limited | 4,797.90 | -0.65% | 29.85 | 160.70 | 21,956 | 5,873.50 | 4,360.10 |
| 7 | SAI PARENTERALS LIMITED | 542.00 | -1.83% | 103.46 | 5.24 | 2,399 | 706.00 | 400.00 |
| 8 | Sanofi India Limited | 3,235.80 | +1.11% | 23.04 | 140.59 | 7,450 | 5,291.00 | 3,054.00 |
| 9 | SANOFI CONS HEALTHC IND L | 4,339.00 | -0.55% | 37.56 | 115.51 | 9,993 | 5,357.00 | 3,975.00 |
| 10 | SENORES PHARMACEUTICALS L | 1,542.40 | -0.30% | 54.30 | 28.39 | 7,109 | 1,562.90 | 662.45 |
| 11 | SMS Pharmaceuticals Limited | 356.35 | -0.28% | 31.78 | 11.24 | 3,337 | 447.80 | 221.02 |
| 12 | TTK Healthcare Limited | 1,116.10 | -2.24% | 21.30 | 52.34 | 1,576 | 1,216.80 | 735.00 |
| Median: 12 Co. | 1,957.85 | -0.29% | 35.17 | 42.44 | 8,722 | 2,044.55 | 1,003.00 |